Abstract
Parkinson’s disease (PD) is one of the most prevalent neurological diseases, described by complex clinical phenotypes. The manifestations of PD include both motor and non-motor symptoms. We constituted an experimental protocol for the assessment of PD motor signs of lower extremities. Using a pair of sensor insoles, data were recorded from PD patients, Elderly and Adult groups. Assessment of PD patients has been performed by neurologists specialized in movement disorders using the Movement Disorder Society—Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)-Part III: Motor Examination, on both ON and OFF medication states. Using as a reference point the quantified metrics of MDS-UPDRS-Part III, severity levels were explored by classifying normal, mild, moderate, and severe levels of PD. Elaborating the recorded gait data, 18 temporal and spatial characteristics have been extracted. Subsequently, feature selection techniques were applied to reveal the dominant features to be used for four classification tasks. Specifically, for identifying relations between the spatial and temporal gait features on: PD and non-PD groups; PD, Elderly and Adults groups; PD and ON/OFF medication states; MDS-UPDRS: Part III and PD severity levels. AdaBoost, Extra Trees, and Random Forest classifiers, were trained and tested. Results showed a recognition accuracy of 88%, 73% and 81% for, the PD and non-PD groups, PD-related medication states, and PD severity levels relevant to MDS-UPDRS: Part III ratings, respectively.
Funder
European Regional Development Fund of the European Union and Greek national funds
Subject
Electrical and Electronic Engineering,Biochemistry,Instrumentation,Atomic and Molecular Physics, and Optics,Analytical Chemistry
Reference66 articles.
1. The emerging evidence of the parkinson pandemic;Dorsey;J. Park. Dis.,2018
2. Stoker, T.B., and Greenland, J.C. (2018). Parkinson’s Disease: Pathogenesis and Clinical Aspects, Codon Publications.
3. The pathogenesis of parkinson’s disease: A complex interplay between astrocytes, microglia, and T lymphocytes?;Copas;Front. Neurol.,2021
4. Parkinson’s disease: Biomarkers, treatment, and risk factors;Emamzadeh;Front. Neurosci.,2018
5. Challenges in the diagnosis of Parkinson’s disease;Tolosa;Lancet Neurol.,2021
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献